Josep Tabernero Caturla-rekin lankidetzan egindako argitalpenak (4)

2017

  1. Professional burnout in European young oncologists: results of the European Society for Medical Oncology (ESMO) Young Oncologists Committee Burnout Survey

    Annals of Oncology, Vol. 28, Núm. 7, pp. 1590-1596

2016

  1. Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO)

    ESMO Open, Vol. 1, Núm. 6

2012

  1. Sorafenib in metastatic thyroid cancer

    Endocrine-Related Cancer, Vol. 19, Núm. 2, pp. 209-216

2011

  1. Phase I pharmacokinetic and pharmacodynamic dose-escalation study of RG7160 (GA201), the first glycoengineered monoclonal antibody against the epidermal growth factor receptor,,in patients with advanced solid tumors

    Journal of Clinical Oncology, Vol. 29, Núm. 28, pp. 3783-3790